Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, A TX synthase inhibitor
- 1 July 1993
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 71 (1) , 69-76
- https://doi.org/10.1016/0049-3848(93)90206-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Enzyme-Linked Immunosorbent Assay of CS-518, a Thromboxane Synthetase Inhibitor, in Rabbit Plasma and PlateletsJournal of Immunoassay, 1992
- Enzyme immunoassay of human plasma 11-dehydrothromboxane B2Thrombosis Research, 1991
- Plasma 11-dehydrothromboxane B2: a reliable indicator of platelet hyperfunction in patients with ischemic strokeActa Neurologica Scandinavica, 1991
- The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damageThrombosis Research, 1990
- Synthesis and thromboxane synthetase inhibitory activity of di- or tetrahydrobenzo[b]thiophenecarboxylic acid derivativesJournal of Medicinal Chemistry, 1989
- RS-5186, a novel thromboxane synthetase inhibitor with a potent and extended duration of actionThrombosis Research, 1988
- Identification of 11-dehydro-TXB2 as a suitable parameter for monitoring thromboxane production in the humanProstaglandins, 1986
- Long-lived enzymatic metabolites of thromboxane B2 in the human circulationAnalytical Biochemistry, 1986
- Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane productionProstaglandins, 1986